In recent research published in Genome Medicine, the authors investigate the relationship between blood cell composition and DNA methylation age, a biomarker often used to estimate biological age. The study highlights how variations in blood cell types, particularly naïve and memory T cells, can significantly influence the results of epigenetic clocks, which are tools for measuring biological age.
What this study does not show
This study does not establish a direct causal relationship between blood cell composition and health outcomes, nor does it imply that changes in blood cell composition can be used to predict mortality or disease incidence.
The researchers utilized a principal component analysis (PCA) method to address the complexities of analyzing blood cell composition, which can be affected by collinearity among cell fractions. Their analysis included a substantial sample size of 4,058 individuals, allowing for a robust examination of how different blood cell types contribute to the estimation of DNA methylation age and age acceleration.
Findings indicated that up to 53% of the variation in DNA methylation age could be attributed to the composition of blood cells, with a notable impact from the balance of naïve and memory T cells. However, the association between age acceleration and cell counts was found to be weaker, explaining only up to 21% of the variance. This suggests that while blood cell composition plays a role in biological aging, it is not the sole factor influencing these epigenetic measures.
Moreover, the study explored the implications of blood cell composition on age acceleration in relation to 176 incident health outcomes across a larger cohort of 18,859 individuals. The results showed that while cell composition did attenuate the association between age acceleration and health outcomes, the effect was modest. This indicates that although blood cell types can influence biological age measurements, their contribution to predicting health outcomes like mortality and disease incidence is limited.
In conclusion, the research presents evidence that DNA methylation age and age acceleration reflect different biological processes, influenced by blood cell composition. This distinction is crucial for understanding how these measures can be interpreted in the context of health and aging.
Evidence scorecard
- Analytic validity: Established
- Clinical validity: Not established
- Clinical utility: Not established
The evidence is based on primary research involving human participants.